Table 1 of Abu El-Asrar, Mol Vis 2017; 23:853-871.
Disease Group | HMGB1 (ng/ml) | 8-OHdG (ng/ml) | sVAP-1 (pg/ml) | HO-1 (RFUs) |
---|---|---|---|---|
All PDR (n=47) | 7.59±3.68 | 7.81±4.86 | 1217.89±590.31 | 236.74±205.26 |
RD (n=19) | 3.89±3.22 | 3.34±1.43 | 421.06±144.82 | 177.61±69.46 |
P value (Mann–Whitney test) | 0.001* | <0.001* | <0.0001* | 0.805 |
Active PDR (n=25) | 8.86±4.24 | 11.02±4.53 | 1705.76±191.94 | 335.14±270.64 |
Inactive PDR (n=22) | 6.08±2.13 | 4.16±1.46 | 663.50±340.37 | 165.18±95.75 |
RD (n=19) | 3.89±3.22 | 3.34±1.43 | 421.06±144.82 | 177.61±69.46 |
P value (Kruskal–Wallis test) | <0.0001* | <0.0001* | <0.0001* | 0.035* |